Glenmark Pharmaceuticals Q4 Result FY26: Net Profit Soars 64x to ₹301 Crore as Company Becomes Debt Free
The Indian pharmaceutical sector has witnessed several remarkable turnaround stories over the years, but Glenmark Pharmaceuticals may have just delivered one of the most impressive…







